Allspring Global Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,763
| Closed | -$216K | – | 1664 |
|
|
2025
Q1 | $216K | Sell |
5,763
-78,258
| -93% | -$2.93M | ﹤0.01% | 1646 |
|
|
2024
Q4 | $4.11M | Sell |
84,021
-9,278
| -10% | -$454K | 0.01% | 983 |
|
|
2024
Q3 | $4.93M | Buy |
93,299
+5,487
| +6% | +$290K | 0.01% | 948 |
|
|
2024
Q2 | $4.76M | Buy |
87,812
+84,396
| +2,471% | +$4.57M | 0.01% | 969 |
|
|
2024
Q1 | $239K | Buy |
3,416
+558
| +20% | +$39.1K | ﹤0.01% | 1671 |
|
|
2023
Q4 | $239K | Sell |
2,858
-1,644
| -37% | -$137K | ﹤0.01% | 1657 |
|
|
2023
Q3 | $133K | Sell |
4,502
-20,534
| -82% | -$605K | ﹤0.01% | 1896 |
|
|
2023
Q2 | $817K | Sell |
25,036
-174,881
| -87% | -$5.7M | ﹤0.01% | 1464 |
|
|
2023
Q1 | $7.04M | Buy |
199,917
+6,157
| +3% | +$217K | 0.01% | 893 |
|
|
2022
Q4 | $8.88M | Buy |
193,760
+1,405
| +0.7% | +$64.4K | 0.02% | 806 |
|
|
2022
Q3 | $9.32M | Buy |
192,355
+6,462
| +3% | +$313K | 0.02% | 800 |
|
|
2022
Q2 | $7.3M | Sell |
185,893
-31,055
| -14% | -$1.22M | 0.01% | 871 |
|
|
2022
Q1 | $7.99M | Sell |
216,948
-1,381
| -0.6% | -$50.8K | 0.01% | 965 |
|
|
2021
Q4 | $9.95M | Buy |
+218,329
| New | +$9.95M | 0.01% | 922 |
|